Conference
Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial
Authors
Ledermann JA; Perren TJ; Raja FA; Embleton A; Rustin GJS; Jayson G; Kaye SB; Swart AM; Vaughan M; Hirte H
Volume
49
Pagination
pp. S5-S6
Publisher
ELSEVIER SCI LTD
Publication Date
September 1, 2013
Conference proceedings
EUROPEAN JOURNAL OF CANCER
ISSN
0959-8049